C12N 2760/20032
Use of virus as therapeutic agent, other than vaccine
Official title: Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
C12N2760/20032 (Use of virus as therapeutic agent, other than vaccine) appears on 13 US grants and 26 published applications in this corpus.
Search patents in C12N- Granted patents
- 13
- Published applications
- 26
- Assignees
- 11
- Inventors
- 28
- Latest grant
- 28 Oct 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2011 | 0 | 1 |
| 2012 | 0 | 1 |
| 2013 | 1 | 1 |
| 2014 | 0 | 3 |
| 2015 | 1 | 2 |
| 2016 | 1 | 1 |
| 2017 | 2 | 1 |
| 2018 | 1 | 1 |
| 2019 | 0 | 3 |
| 2020 | 1 | 2 |
| 2021 | 1 | 4 |
| 2022 | 0 | 1 |
| 2023 | 2 | 1 |
| 2024 | 1 | 2 |
| 2025 | 2 | 1 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Recombinant rhabdovirus encoding for CCL2128 Oct 2025US 12,453,749 B2Boehringer Ingelheim International GmbH
- Recombinant oncolytic virus8 Jul 2025US 12,351,812 B2Georgia State University Research Foundation, Inc.
- Recombinant rhabdovirus encoding for a CD80 extracellular domain Fc-fusion protein24 Dec 2024US 12,171,795 B2Boehringer Ingelheim International GmbH
- Recombinant rhabdovirus encoding for CCL2125 Jul 2023US 11,707,495 B2Boehringer Ingelheim International GmbH
- Compositions and methods for glioblastoma treatment23 May 2023US 11,654,192 B2Children's Hospital of Eastern Ontario Research Institute Inc.
- Neddylation-activating enzyme inhibitors as viral sensitizers and uses thereof15 Jan 2026US 2026/0015592 A1Ottawa Hospital Research Institute
- Recombinant rhabdovirus encoding for a CD80 extracellular domain Fc-fusion protein20 Feb 2025US 2025/0057900 A1Boehringer Ingelheim International GmbH
- Or2l13 agonists to treat cvd with dysregulated platelet activation4 Apr 2024US 2024/0108591 A1The Cleveland Clinic Foundation
- Recombinant rhabdovirus encoding for ccl214 Jan 2024US 2024/0000874 A1Boehringer Ingelheim International GmbH
- Compositions and methods for glioblastoma treatment21 Sep 2023US 2023/0293668 A1Children's Hospital of Eastern Ontario Research Institute Inc.
Most cited
By later US patents